Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)-Reference-Cited by-同舟云学术

Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)

Published:2024-03-25 Issue:3 Volume:25 Page:485-496
ISSN:1175-0561
Container-title:American Journal of Clinical Dermatology
language:en
Short-container-title:Am J Clin Dermatol

Author:

Silverberg Jonathan I.^ORCID,Gooderham Melinda J.^ORCID,Paller Amy S.^ORCID,Deleuran Mette^ORCID,Bunick Christopher G.^ORCID,Gold Linda F. Stein,Hijnen DirkJan^ORCID,Calimlim Brian M.^ORCID,Lee Wan-Ju^ORCID,Teixeira Henrique D.,Hu Xiaofei^ORCID,Zhang Shiyu,Yang Yang^ORCID,Grada Ayman^ORCID,Platt Andrew M.^ORCID,Thaçi Diamant^ORCID

Funder

AbbVie

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40257-024-00853-4.pdf

Reference36 articles.

1. Kantor R, Silverberg JI. Environmental risk factors and their role in the management of atopic dermatitis. Expert Rev Clin Immunol. 2017;13(1):15–26. https://doi.org/10.1080/1744666x.2016.1212660.

2. Ständer S. Atopic dermatitis. N Engl J Med. 2021;384(12):1136–43. https://doi.org/10.1056/NEJMra2023911.

3. Kim J, Kim BE, Leung DYM. Pathophysiology of atopic dermatitis: clinical implications. Allergy Asthma Proc. 2019;40(2):84–92. https://doi.org/10.2500/aap.2019.40.4202.

4. Laughter MR, Maymone MBC, Mashayekhi S, Arents BWM, Karimkhani C, Langan SM, et al. The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990–2017. Br J Dermatol. 2021;184(2):304–9. https://doi.org/10.1111/bjd.19580.

5. Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, et al. Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study. Ann Allergy Asthma Immunol. 2018;121(3):340–7. https://doi.org/10.1016/j.anai.2018.07.006.